Autopilot 2.0 Chain AI agents into full outbound flows Read more →
Product
AI Sales Agents Prospector Intent & Signals Visitor Tracking Reply Handler Email Automation LinkedIn Automation Autopilot
Solutions
TAM sourcing Automated outbound Sales RevOps Enterprise Startups
Resources
The Report Blog Salestools University Guides GPT Prompts ROI Calculator Help Center
Company
Our Team Careers Customers Partner Program Pricing Changelog
Language
Get a demo Start free trial Log in

Le rapport

Analyses approfondies du financement des entreprises, des stratégies de croissance et des insights de marché des entreprises les plus innovantes du monde

196 rapports et plus encore

Mis à jour quotidiennement avec les dernières informations de marché
Biotechnology
Kailera Therapeutics

Kailera Therapeutics Raises $400 Million in Series A - October 2024

Kailera Therapeutics announced $400 Million in Series A funding at a Undisclosed valuation. Kailera Therapeutics raised a massive $400 million Series A to develop clinical-stage injectable and oral therapies for chronic weight management and ...

James Rodriguez
Oct 26, 2025
0 min read•$400 Million
Biotech
Kailera Therapeutics

Kailera Therapeutics raises $400M Series A at $1.5B valuation

Kailera Therapeutics raises $400M in Series A at $1.5B valuation. Developing obesity therapeutics with acquired pipeline...

Editorial Team
Oct 1, 2024
0 min read•$400M
Fundraising
Kailera Therapeutics

Kailera Therapeutics Raises $400M in Series A

Kailera Therapeutics, a Biotech company based in Cambridge, MA, has raised $400M in Series A at a $1.5B valuation led by Atlas Venture, Bain Capital Life Sciences.

Fundraising News Team
Oct 1, 2024
0 min read
Biotech
Kailera Therapeutics

Kailera Therapeutics Raises $600M Series B to Transform Biotech

Kailera Therapeutics has secured $600M Series B in funding to accelerate growth and innovation in the biotech sector. Clinical-stage biopharmaceutical company developing novel obesity therapeutics targeting metabolic pathways...

Emma Rodriguez
Oct 22, 2025
0 min read•$600M Series B
HealthTech
Arnatar Therapeutics

Arnatar Therapeutics raises $52M Series A

Arnatar Therapeutics raises $52M in Series A. Developing therapeutics for autoimmune and inflammatory diseases...

Editorial Team
Aug 25, 2025
0 min read•$52M
Biotech
Denali Therapeutics

Denali Therapeutics raises $217M Series C at $5B valuation

Denali Therapeutics raises $217M in Series C at $5B valuation. Neurodegeneration therapeutics...

Editorial Team
Mar 6, 2024
0 min read•$217M
HealthTech
Strand Therapeutics

Strand Therapeutics raises $153M Series B

Strand Therapeutics raises $153M in Series B. mRNA-based therapeutics developer with novel cancer treatment platform...

Editorial Team
Sep 17, 2025
0 min read•$153M
Biotech
Seres Therapeutics

Seres Therapeutics raises $113M Series E at $450M valuation

Seres Therapeutics raises $113M in Series E at $450M valuation. Microbiome therapeutic platform...

Editorial Team
Jan 19, 2024
0 min read•$113M
Biotech
Crystalys Therapeutics

Crystalys Therapeutics raises $205M Series B at $900M valuation

Crystalys Therapeutics raises $205M in Series B at $900M valuation. Developing novel therapeutics for neurodegenerative diseases...

Editorial Team
Oct 1, 2025
0 min read•$205M
Page 1

Affichage de 9 rapports • Page 1 • Catégorie : all

Restez en avance sur le marché

Recevez des insights hebdomadaires dans votre boîte de réception. Pas de spam, juste de l'intelligence.